Singapore markets close in 2 hours 3 minutes
Straits Times Index
3,304.52 +7.63 (+0.23%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,503.70 +296.57 (+1.63%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,297.64 +1,754.20 (+3.05%) CMC Crypto 200
1,294.48 +17.51 (+1.37%)
ORIC Pharmaceuticals, Inc. (ORIC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.33 |
| Open | 9.29 |
| Bid | 9.47 x 400 |
| Ask | 9.54 x 200 |
| Day's range | 9.29 - 9.69 |
| 52-week range | 4.90 - 16.65 |
| Volume | |
| Avg. volume | 589,126 |
| Market cap | 641.86M |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%
The mean of analysts' price targets for Oric Pharmaceuticals (ORIC) points to a 39.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- GuruFocus.com
ORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Results
Advances in Clinical Programs and Strengthened Cash Position Highlighted
- GuruFocus.com
ORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Shares
Jacob Chacko, the President and Chief Executive Officer of ORIC Pharmaceuticals Inc (NASDAQ:ORIC), has sold 40,000 shares of the company on March 6, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.